DLPIC
BMY icon

Davide Leone & Partners Investment Company’s Bristol-Myers Squibb BMY Stock Holding History

Davide Leone & Partners Investment Company’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,000,000
Closed -$95.4M – 18
2019
Q1 		$95.4M Buy
+2,000,000
New +$99.6M 7.04% 4
2018
Q1 		– Sell
-1,540,400
Closed -$94.4M – 18
2017
Q4 		$94.4M Hold
1,540,400
– – 6.08% 6
2017
Q3 		$98.2M Sell
1,540,400
-12,400
-0.8% -$724K 8.75% 5
2017
Q2 		$86.5M Buy
+1,552,800
New +$84.5M 7.37% 5

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Davide Leone & Partners Investment Company's BMY Position: Q3 2018 in Review

Davide Leone & Partners Investment Company sold out of Bristol-Myers Squibb (BMY) in Q3 2018, closing a stake of 1,433,400 shares — an estimated $79.3M sold.

Davide Leone & Partners Investment Company first reported a position in BMY in Q2 2014 and held it in 9 quarters. The position peaked at $79.3M in Q2 2018. 1,730 funds tracked by Wall St. Rank hold BMY as of Q3 2018.

  • Davide Leone & Partners Investment Company reported no remaining Bristol-Myers Squibb position as of Q3 2018 after selling out during the quarter.
  • Davide Leone & Partners Investment Company sold 1,433,400 Bristol-Myers Squibb shares in Q3 2018, an estimated $79.3M.
  • Davide Leone & Partners Investment Company first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 9 quarters.
  • Davide Leone & Partners Investment Company's Bristol-Myers Squibb position peaked at $79.3M in Q2 2018.
  • 1,730 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2018.

Based on Davide Leone & Partners Investment Company's 13F filing for Q3 2018, filed 14 Nov 2018.